Structuring pharmacovigilance
Pharmacovigilance- Adverse drug reaction monitoring
Article REF: PHA3060 V1
Structuring pharmacovigilance
Pharmacovigilance- Adverse drug reaction monitoring

Author : Elisabeth POLARD

Publication date: June 10, 2016, Review date: May 27, 2020 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

1. Structuring pharmacovigilance

Caregivers have always been concerned to avoid iatrogenic medication in their patients. Hippocrates' primum non nocere has always been the rule. However, awareness of the risk of serious adverse drug reactions (ADRs) arose quite recently and brutally with the thalidomide tragedy, a drug presumed harmless in the early days of its use. Ten years later, the sad experience of diethylstilbestrol showed that systematic and prolonged drug monitoring is necessary to assess the risk profile of ...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us